Ento Proteins Private Limited - Due diligence report

A 360° intelligence report on Ento Proteins Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2021-03-08 Mangalore, Karnataka Active Unlisted
Share
EP Ento Proteins Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ento Proteins Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Ento Proteins Private Limited is assessed as Low Risk with a Trust Score of 76/100. Ento Proteins Private Limited is an active private limited indian non-government company incorporated in 2021, operating in the Agriculture sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Ento Proteins Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
92/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Profitable - internal accruals available.

Charges position: 1 open (3.50 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Compliance Score: 92/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Delayed payments to MSME suppliers disclosed (46 disclosure(s)).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
KALANDAN MOHAMMED HARIS 01234567 Director 01/04/2018 6 yrs Approved
KALANDAN MOHAMMAD ARIF 01234567 Director 01/04/2018 6 yrs Approved
KALANDAN MOHAMMED ALTHAF 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Mukka Proteins Limited
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 1 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Group entityRelationship% held
Mukka Proteins Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 60
Growth signals & trust indicators
Latest year revenue grew 38%.
Profit expanded 1.42 year-on-year.
Asset base grew 2.1x - capacity expansion.
Net margin improved to 24%.
Operating for 5 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
Negative net worth.
1 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 1.83 cr.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence78/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment67/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 3.50 cr already registered.
  • Compliance record supports lending.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 9 events
29 Aug 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
20 Sep 2023
Charge created
Hdfc Bank Limited - 3.50 cr
31 Mar 2023
Share transfer (FY 2023)
1.00000000 shares to Mukka Protiens Limited
19 Oct 2021
Securities allotted
1000 Equity Shares - 1.00 Lakh raised
08 Mar 2021
Incorporated
Registered with Roc Bangalore
Director appointed
KALANDAN MOHAMMED HARIS (Director)
Director appointed
KALANDAN MOHAMMAD ARIF (Director)
Director appointed
KALANDAN MOHAMMED ALTHAF (Director)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2023 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Goldtheme Gems Private Limited U74999RJ2018PTC061011 Jaipur, Rajasthan, India
Bio Leaf Manufacturing Private Limited U25209HR2021PTC093611 Gurgaon, Haryana, India
Sonar Instruments And Technology Private Limited U29253DL2007PTC171327 Delhi, Delhi, India
Valvetork Control India Private Limited U29253TZ2015PTC021534 Coimbatore, Tamil Nadu, India
Sk Ensure Machinery Private Limited U29309HR2019PTC077996 Faridabad, Haryana, India
Vedika Machinery U29253WB2009PTC136248 Kolkata, West Bengal, India
Calvin And Beaver Sports Private Limited U36939PB2003PTC026203 Zirakpur, Punjab, India
Rosvenger Pharma U33309GJ2016PTC093589 Ahmedabad, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ento Proteins Private Limited before audits and certifications: compliance score 92/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ento Proteins Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 80/100, margin trends, ownership structure and peer set for Ento Proteins Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Ento Proteins Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Ento Proteins Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ento Proteins Private Limited an active company?

Ento Proteins Private Limited has MCA status “Active” with a compliance score of 92/100 (Low Risk).

Is Ento Proteins Private Limited financially healthy?

Ento Proteins Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Ento Proteins Private Limited?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ento Proteins Private Limited?

The ultimate holding entity is Mukka Proteins Limited. 3 active director(s) are on record.

Does Ento Proteins Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Ento Proteins Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 92/100 (Low Risk).

Is it risky to lend to Ento Proteins Private Limited?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.